Susquehanna International Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,454
Closed -$37.6K 13561
2023
Q1
$37.6K Sell
32,454
-1,125
-3% -$2.06K ﹤0.01% 11823
2022
Q4
$90K Buy
33,579
+11,363
+51% +$30K ﹤0.01% 11052
2022
Q3
$64K Sell
22,216
-20,953
-49% -$89.1K ﹤0.01% 12053
2022
Q2
$215K Buy
43,169
+6,991
+19% +$36.6K ﹤0.01% 10467
2022
Q1
$257K Sell
36,178
-60,724
-63% -$502K ﹤0.01% 10652
2021
Q4
$1.76M Sell
96,902
-29,629
-23% -$639K ﹤0.01% 5805
2021
Q3
$2.48M Buy
126,531
+29,393
+30% +$1.12M ﹤0.01% 5375
2021
Q2
$4.35M Sell
97,138
-2,255
-2% -$105K ﹤0.01% 4283
2021
Q1
$4.99M Buy
99,393
+91,046
+1,091% +$6.21M ﹤0.01% 3917
2020
Q4
$746K Buy
+8,347
New +$702K ﹤0.01% 7377

Other funds holding CELL

Susquehanna International Group's CELL Position: Q2 2023 in Review

Susquehanna International Group sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2023, closing a stake of 32,454 shares — an estimated $37.6K sold.

Susquehanna International Group first reported a position in CELL in Q4 2020 and held it in 10 quarters. The position peaked at $4.99M in Q1 2021. 84 funds tracked by Wall St. Rank hold CELL as of Q2 2023.

  • Susquehanna International Group reported no remaining PhenomeX Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 32,454 PhenomeX Inc. Common Stock shares in Q2 2023, an estimated $37.6K.
  • Susquehanna International Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Susquehanna International Group's PhenomeX Inc. Common Stock position peaked at $4.99M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.